- Home
- PLSE vs CLOV Comparison
PLSE vs CLOV Comparison
Compare PLSE & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | CLOV |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PLSE | CLOV |
|---|---|---|
| Price | $25.33 | $3.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $22.00 | $2.90 |
| AVG Volume (30 Days) | 366.1K | ★ 8.3M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.03 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $1,924,308,000.00 |
| Revenue This Year | $840.00 | $52.59 |
| Revenue Next Year | $287.54 | $15.37 |
| P/E Ratio | ★ N/A | $79.80 |
| Revenue Growth | N/A | ★ 40.34 |
| 52 Week Low | $12.56 | $1.58 |
| 52 Week High | $28.53 | $4.23 |
Technical Indicators
Market Signals| Indicator | PLSE | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 62.72 |
| Support Level | $17.58 | $2.44 |
| Resistance Level | $26.30 | $4.23 |
| Average True Range (ATR) | 1.62 | 0.23 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 28.60 | 58.80 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.